Detalhe da pesquisa
1.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048793
2.
Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
Oncologist
; 29(1): 1-7, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700450
3.
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders.
J Med Genet
; 60(7): 685-691, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36446584
4.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Lancet Oncol
; 24(3): 273-285, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858723
5.
Role of psychological background in cancer susceptibility genetic testing distress: It is not only about a positive result.
J Genet Couns
; 32(4): 778-787, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748747
6.
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Future Oncol
; 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200668
7.
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation.
Int J Gynecol Cancer
; 2022 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35444013
8.
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.
Radiology
; 299(1): 109-119, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33497314
9.
Patients' and professionals' perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic.
Genet Med
; 23(8): 1450-1457, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824504
10.
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysis.
Ann Hematol
; 100(12): 2969-2978, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378095
11.
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy.
Ann Hematol
; 100(9): 2303-2310, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34236497
12.
Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis.
Eur Radiol
; 31(3): 1460-1470, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32909055
13.
Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
Br J Haematol
; 190(6): 854-863, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32519351
14.
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes.
Ann Hematol
; 97(8): 1349-1356, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572561
15.
First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies.
Clin Genitourin Cancer
; 22(2): 330-335, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172023
16.
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy.
NPJ Breast Cancer
; 10(1): 20, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448600
17.
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.
Clin Cancer Res
; 30(4): 895-903, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078899
18.
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
EBioMedicine
; 102: 105043, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447275
19.
Comprehensive evaluation of surrogate endpoints to predict overall survival in trials with PD1/PD-L1 immune checkpoint inhibitors plus chemotherapy.
Cancer Treat Rev
; 116: 102542, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003083
20.
Landscape of neoadjuvant therapy in HER2-positive breast cancer: a systematic review and network meta-analysis.
Eur J Cancer
; 190: 112885, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142539